Abstract
The major challenge in the treatment of cancer is control of metastasis. In most instances, a tumor can be managed initially with chemotherapy, radiation therapy and/or surgery. In many cases, however, tumor cells escape from the primary site, traverse the vascular beds and may adhere to the vascular endothelium at distant sites. Subsequently growth and proliferation of the tumor occurs resulting in clinical metastasis. There is evidence that tumor cell-platelet-vessel wall interactions are important in the process of metastasis. Several platelet-, vessel wall- and tumor cell-generated prostaglandins (PG) are important in these interactions. The purpose of this paper is to review the current information on the role that these prostaglandins may have in the regulation of tumor metastasis (see also Chapter 14).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Weiss HJ. N. Engl. J. Med. 293: 531–580, 1975.
Honn KV, Cicone B and Skoff A. Science 212: 1270–1272, 1981.
Wood S, Jr., Holyoke ED and Yardley JH. Proc. Can. Cancer Res. Gonf. 4: 167–223, 1961.
Wood S, Jr. Bull. Schweiz. Akad. Ifed. Wiss. 20: 92–121, 1964.
Warren BA and Vales O. Br. J. Exp. Pathol. 53: 301–313, 1972.
Jones DS, Wallace AC and Fraser EF. J. Natl. Cancer Inst. 46: 493–504, 1971.
Sindelar WF, Tralica TS and Ketcham AS. J. Surg. Res. 18: 137–161, 1975.
Gasic GJ, Gasic TB, Galanti N, Johnson T and Murphy S. Int. J. Cancer 11: 704–718, 1973.
Gasic G, Gasic T and Stewart CC. Proc. Natl. Acad. Sci. USA 61: 46–53, 1968.
Hilgard P, Heller H and Schmidt CG. Z. Krebsforsch. 86: 243–250, 1976.
Pearlstein E, Salk PL, Yogeeswaran G and Karpatkin S. Proc. Natl. Acad. Sci. USA 77: 4336–4339, 1980.
Gasic GJ, Boettiger D, Catalfamo JL, Gasic TB and Stewart GJ. Cancer Kes. 38: 2950–2955, 1978.
Pearlstein E, Cooper LB and Karpatkin S. J. Lab. Clin. Med. 93: 332–334, 1979.
Honn KV, Cavanaugh P, Evens C, Taylor JD and Sloane BF. Science 217: 540–542,1982.
Paul D, Niewiarowski S, Kodungallore GV, Rucinski B, Rucker S and Lange E. Proc. Natl. Acad. Sci. USA 77: 5914–5918, 1980.
Nachman RL, Weksler B and Ferris B. Annu. Rev. Med. 30: 119–134, 1979.
Holinsen H and Weiss HJ. Annu. Rev. Med. 30: 119–134, 1979.
Kohler N and Upton A. Proc. Am. Assoc. Cancer Res. 18: 244A, 1977.
Cowan DH and Graham J. Froc. Am. Assoc. Cancer Res. 22: 56A, 1981.
Witoski E, Kapner N, Jefferson LS and Lipton A. Proc. Am. Assoc. Cancer Res. 22: 57A, 1981.
Moncada S and Vane JR. N. Engl. J. Med. 300: 1142–1147, 1979.
Honn KV, Busse WD and Sloane BF. Biochem. Pharmacol. 32: 1–11, 1983.
Bennett A, Berstock DA, Harris M, Raja B, Rove DJF, Stanford F ana Wright JE. Adv. Prostaglandin Thranbaxane Res. 6: 595–600, 1980.
Humes JL, Cupo JJ, Jr. and Strausser HR. Prostaglandins 6: 463–473, 1974.
Jaffe BM, Philpott GW, Hampricht B and Parker CW. Adv. Biosci. 9: 179, 1973.
Bananarstrom S, Samuelsson B and Bjursel G. Nature (London) New Biol. 243: 50–51, 1973.
Gonzalez-Crussi F, Hsueh W and Wiederhold MD. Am. J. CLin. Pathol. 75: 24–253, 1981.
Fitzpatrick FA and Stringfellow DA. Proc. Natl. Acad. Sci. USA 76: 1765–1769, 1979.
Chang WC, Muroto S and Tsurufuji S. Prostaglandins 13: 17–25, 1977.
Honn KV, Meyer J, Neagos G, Henderson T, Westley C and Ratanatharathorn V. In: Interactions of Platelets and Timor Cells (Ed. Jamieson GA), Alan Liss, New York, pp. 295–331, 1982.
Tashjian AH, Jr., Voelkel EF, Levin L and Goldhaver P. J. Exp. Med. 136: 1329–1343, 1972.
Powles TJ, CLark SA, Easty EM, Easty GC and Neville A. Br. J. Cancer 28: 316–321, 1973.
Dowsett M, Easty GC, Powles TJ, Easty EM and Neville AM. Prostaglandins 11: 447–460, 1976.
Honn KV and Meyer J. Biochem. Biophys. Res. Commun. 102: 1122–1129, 1981.
Mehta P, Gross S and Ostrowski N. Am. J. Pediat. Hematol. Oncol, (in press),1983.
Mehta P, Springfield D and Ostrowski N. Cancer (Philadelphia) (in press), 1983.
Mehta P, Gross S, Ostrowski N and Brigmon L. Blood (Suppl): 218A, 1982.
Mshta P. Blood (in press), 1983.
Chen YC, McLeod B, Hall EE and Wu KK. Lancet 2: 267–269, 1981.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Mehta, P. (1984). Evidence for Altered Arachidonic Acid Metabolism in Tumor Metastasis. In: Honn, K.V., Sloane, B.F. (eds) Hemostatic Mechanisms and Metastasis. Developments in Oncology, vol 22. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3831-4_15
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3831-4_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3833-8
Online ISBN: 978-1-4613-3831-4
eBook Packages: Springer Book Archive